Current Issue
Nov, 2024 Vol.41 No. 4
-
-
원보J. Kor. Soc. Health-syst. Pharm. 2024; 41(4): 337-353
Policy Research for Enhancing Institutional Narcotic Management Systems
Kyu-Ri Kima*, Jimin Hanb*, Seunghyun Cheona, Yun Hee Joc, Im Soon Choid, Hyungsoon Leee, Hyun-A Sohnf, Sookhee Ang, Kyong Ju Jungh† and Jee-Eun Chunga,† -
원보J. Kor. Soc. Health-syst. Pharm. 2024; 41(4): 354-372
Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma Based on Viral Etiology
Jae Yeon Leea, Min Jung Geuma, Jong Hee Koa, Eun Sun Sona† and Yun Mi Yub† -
원보J. Kor. Soc. Health-syst. Pharm. 2024; 41(4): 373-388
Treatment Status of Parenteral Nutrition-Associated Cholestasis in Pediatric Patients at a Single Tertiary Hospital
Soh Yeon Parka, Yu Jeong Sona, Min Jung Geuma, Jong Hee Koa, Eun Sun Sona†, Yun Mi Yub† and Eun Joo Leec -
원보J. Kor. Soc. Health-syst. Pharm. 2024; 41(4): 389-401
Recent Status of Data Monitoring Committee Guidelines ; Focus on the Clinical Trial Guidelines of Foreign Regulatory Authorities
Chae Jeong Kima, Dayeon Jeonga,b, Min Jung Changc,d,e,f, Jongsung Hahng and Kyung Hee Choia,h† -
종설J. Kor. Soc. Health-syst. Pharm. 2024; 41(4): 402-413
A Comparative Study of International Regulatory Framework for Anti-Cancer Immune Cell Therapies
Jongyoon Kim*, Kyung-Seon Oh* and Hyang-Mi Lee† -
-
Journal Info
Editorial Office
- +82-2-583-0887
- +82-2-521-5629
- office@jkshp.or.kr
- www.kshp.or.kr
Most Read
-
-
-
-
-
원보J. Kor. Soc. Health-syst. Pharm. 2023; 40(2): 195-210
Incidence and Risk Factors for QT Prolongation associated with Fluoroquinolones
Eun Jung Choia,b, Jin Seon Beoma, Hyo Cho Ahna, Seung Yong Parkb,c and Heung Bum Leeb,c†